 | • レポートコード：MRC2304J0094 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、249ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、世界の細胞培養市場規模は、2021年215.8億ドルから2022年に248.7億ドルへと拡大、その後2027年までに年平均15.30％成長して507.2億ドルに達する見通しです。本書は、細胞培養の世界市場を対象とした調査・分析結果を整理したものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析（消耗品、機器）、用途別分析（バイオ医薬品製造、細胞バンク、診断、医薬品スクリーニング＆開発、幹細胞研究）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目を掲載しています。なお、本書には、CellGenix GmbH、Corning Incorporated、Danaher Corporation、Emulate, Inc.、Eppendorf AG、Fujifilm Holdings Corporation、Hi-Media Laboratories、InSphero AG、Invivogen、Lonza Group、Merck & Co., Inc.、Miltenyi Biotecなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の細胞培養市場規模：製品別 - 細胞培養用消耗品の市場規模 - 細胞培養用機器の市場規模 ・世界の細胞培養市場規模：用途別 - バイオ医薬品製造における市場規模 - 細胞バンクにおける市場規模 - 診断における市場規模 - 医薬品スクリーニング＆開発における市場規模 - 幹細胞研究における市場規模 ・世界の細胞培養市場規模：地域別 - 南北アメリカの細胞培養市場規模 アメリカの細胞培養市場規模 カナダの細胞培養市場規模 ブラジルの細胞培養市場規模 ... - アジア太平洋の細胞培養市場規模 日本の細胞培養市場規模 中国の細胞培養市場規模 インドの細胞培養市場規模 韓国の細胞培養市場規模 台湾の細胞培養市場規模 ... - ヨーロッパ/中東/アフリカの細胞培養市場規模 イギリスの細胞培養市場規模 ドイツの細胞培養市場規模 フランスの細胞培養市場規模 ロシアの細胞培養市場規模 ... - その他地域の細胞培養市場規模 ・競争状況 ・企業情報 |
The Global Cell Culture Market size was estimated at USD 21.58 billion in 2021 and expected to reach USD 24.87 billion in 2022, and is projected to grow at a CAGR 15.30% to reach USD 50.72 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cell Culture to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Consumables and Equipment. The Consumables is further studied across Bioreactor Accessories, Sera, Media, and Reagents, and Vessels. The Sera, Media, and Reagents is further studied across Media, Reagents, and Sera. The Media is further studied across Classical Media & Salts, Serum-Free Media, Specialty Media, and Stem Cell Culture Media. The Reagents is further studied across Antibiotics/Antimycotics, Attachment & Matrix Factors, Balanced Salt Solutions, Buffers & Chemicals, Cell Dissociation Reagents, Contamination Detection Kits, and Cryoprotective Reagents. The Sera is further studied across Adult Bovine Sera and Fetal Bovine Sera. The Vessels is further studied across Cell Factory Systems/Cell Stacks, Flasks, Multiwell Plates, Petri Dishes, and Roller/Roux Bottles. The Equipment is further studied across Bioreactors, Storage Equipment, and Supporting Equipment. The Bioreactors is further studied across Conventional Bioreactors and Single-Use Bioreactors. The Storage Equipment is further studied across Cryostorage System and Refrigerators & Freezers. The Supporting Equipment is further studied across Autoclaves, Biosafety Cabinets, Carbon Dioxide Incubators, Cell Counters, Centrifuges, Filtration System, and Microscopes.
Based on Application, the market was studied across Biopharmaceutical Production, Cell Banking, Diagnostics, Drug Screening & Development, Stem Cell Research, and Tissue Engineering & Regenerative Medicine.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell Culture market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Culture Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Culture Market, including CellGenix GmbH, Corning Incorporated, Danaher Corporation, Emulate, Inc., Eppendorf AG, Fujifilm Holdings Corporation, Hi-Media Laboratories, InSphero AG, Invivogen, Lonza Group, Merck & Co., Inc., Miltenyi Biotec, PromoCell GmbH, Sartorius AG, Synthecon, Incorporated, Thermo Fisher Scientific Inc., and VWR International, LLC by Avantor, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cell Culture Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Culture Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Culture Market?
4. What is the competitive strategic window for opportunities in the Global Cell Culture Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Culture Market?
6. What is the market share of the leading vendors in the Global Cell Culture Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell Culture Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Population Suffering from Increasing Incidences of Various Diseases
5.1.1.2. Increasing Regulatory Approvals for Cell-Culture-Based Vaccines
5.1.1.3. Increasing use of 3D Cell Culture in Organ Transplantation and Drug Screening
5.1.2. Restraints
5.1.2.1. Limited Availability of Skilled Professionals and the Associated High Cost
5.1.3. Opportunities
5.1.3.1. Developed Biotechnology and Pharmaceutical Industry
5.1.3.2. Growing Demand for 3D Cell Culture and Integrated Cell Culture-Mass Spectrometry Method
5.1.4. Challenges
5.1.4.1. Incompatibilities of analytical technologies with 3D cell culture
5.2. Cumulative Impact of COVID-19
6. Cell Culture Market, by Product
6.1. Introduction
6.2. Consumables
6.3.1. Bioreactor Accessories
6.3.2. Sera, Media, and Reagents
6.3.3.1. Media
6.3.3.2.1. Classical Media & Salts
6.3.3.2.2. Serum-Free Media
6.3.3.2.3. Specialty Media
6.3.3.2.4. Stem Cell Culture Media
6.3.3.2. Reagents
6.3.3.3.1. Antibiotics/Antimycotics
6.3.3.3.2. Attachment & Matrix Factors
6.3.3.3.3. Balanced Salt Solutions
6.3.3.3.4. Buffers & Chemicals
6.3.3.3.5. Cell Dissociation Reagents
6.3.3.3.6. Contamination Detection Kits
6.3.3.3.7. Cryoprotective Reagents
6.3.3.3. Sera
6.3.3.4.1. Adult Bovine Sera
6.3.3.4.2. Fetal Bovine Sera
6.3.3. Vessels
6.3.4.1. Cell Factory Systems/Cell Stacks
6.3.4.2. Flasks
6.3.4.3. Multiwell Plates
6.3.4.4. Petri Dishes
6.3.4.5. Roller/Roux Bottles
6.3. Equipment
6.4.1. Bioreactors
6.4.2.1. Conventional Bioreactors
6.4.2.2. Single-Use Bioreactors
6.4.2. Storage Equipment
6.4.3.1. Cryostorage System
6.4.3.2. Refrigerators & Freezers
6.4.3. Supporting Equipment
6.4.4.1. Autoclaves
6.4.4.2. Biosafety Cabinets
6.4.4.3. Carbon Dioxide Incubators
6.4.4.4. Cell Counters
6.4.4.5. Centrifuges
6.4.4.6. Filtration System
6.4.4.7. Microscopes
7. Cell Culture Market, by Application
7.1. Introduction
7.2. Biopharmaceutical Production
7.3. Cell Banking
7.4. Diagnostics
7.5. Drug Screening & Development
7.6. Stem Cell Research
7.7. Tissue Engineering & Regenerative Medicine
8. Americas Cell Culture Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Cell Culture Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Cell Culture Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. CellGenix GmbH
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Corning Incorporated
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Danaher Corporation
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Emulate, Inc.
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Eppendorf AG
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Fujifilm Holdings Corporation
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Hi-Media Laboratories
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. InSphero AG
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Invivogen
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Lonza Group
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Merck & Co., Inc.
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Miltenyi Biotec
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. PromoCell GmbH
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Sartorius AG
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Synthecon, Incorporated
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Thermo Fisher Scientific Inc.
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. VWR International, LLC by Avantor, Inc.
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing